G9077
Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
- Effective Date: 2006-01-01
- Medicare Coverage Status: Carrier Judgement
- BETOS Classification: Oncology - other
Medicare has not assigned a fee schedule for this code
G9075
G9078 